- Home
- NEGG vs STRO Comparison
NEGG vs STRO Comparison
Compare NEGG & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- STRO
- Stock Information
- Founded
- NEGG 2001
- STRO 2003
- Country
- NEGG United States
- STRO United States
- Employees
- NEGG N/A
- STRO N/A
- Industry
- NEGG Other Specialty Stores
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEGG Consumer Discretionary
- STRO Health Care
- Exchange
- NEGG Nasdaq
- STRO Nasdaq
- Market Cap
- NEGG 122.3M
- STRO 77.7M
- IPO Year
- NEGG 2010
- STRO 2018
- Fundamental
- Price
- NEGG $16.83
- STRO $0.76
- Analyst Decision
- NEGG
- STRO Hold
- Analyst Count
- NEGG 0
- STRO 7
- Target Price
- NEGG N/A
- STRO $3.97
- AVG Volume (30 Days)
- NEGG 1.3M
- STRO 1.4M
- Earning Date
- NEGG 08-28-2025
- STRO 08-12-2025
- Dividend Yield
- NEGG N/A
- STRO N/A
- EPS Growth
- NEGG N/A
- STRO N/A
- EPS
- NEGG N/A
- STRO N/A
- Revenue
- NEGG $1,235,576,000.00
- STRO $66,434,000.00
- Revenue This Year
- NEGG N/A
- STRO N/A
- Revenue Next Year
- NEGG N/A
- STRO N/A
- P/E Ratio
- NEGG N/A
- STRO N/A
- Revenue Growth
- NEGG N/A
- STRO N/A
- 52 Week Low
- NEGG $3.32
- STRO $0.52
- 52 Week High
- NEGG $26.40
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- NEGG 69.10
- STRO 44.92
- Support Level
- NEGG $15.00
- STRO $0.67
- Resistance Level
- NEGG $17.74
- STRO $0.79
- Average True Range (ATR)
- NEGG 2.00
- STRO 0.07
- MACD
- NEGG 0.44
- STRO -0.01
- Stochastic Oscillator
- NEGG 90.44
- STRO 34.52
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.